Fig. 1.

Patient selection and study design. From the 2,180 reviewed patients with HCC before their initial treatment, we excluded those diagnosed with viral hepatitis, autoimmune hepatitis, primary biliary cholangitis, and glycogen storage disease, and selected 237 patients with hepatic steatosis determined by pathological or ultrasonography findings